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Abstract 
Many viruses are known to undergo rapid evolutionary changes under selective pressures. 
The HIV-1 envelope glycoprotein 120 (gp120) shows extreme selection for NXS/T sequons, 
the potential sites of N-glycosylation. Although the average number of sequons in gp120 
appears to be relatively stable in the recent past, even slight changes in the distribution of 
sequons may potentially play crucial roles in protein interaction and viral infection. This study 
tracked the prevalence and distribution of NXS/T sequons in gp120 over a period of 29 years 
(from 1981 to 2009). The gp120 showed location specific distribution of sequons with higher 
density in the outer domain of the molecule. The NXT sequon density decreased in the outer 
domain (despite the increase in the sequon specific amino acid threonine), but increased in the 
inner domain. By contrast, the NXS sequon density increased specifically in the outer domain. 
Related changes were also seen in the distribution probabilities of sequons in two domains. 
The results indicate that the gp120, chiefly in subtype B, is redistributing NXS/T sequons 
within the molecule with specific selection for NXS sequons. The subtle evolution of sequons 
in gp120 may have implications in viral resistance and infection.  
Key words: Molecular evolution, Glycoprotein, Human immunodeficiency virus, N-glycosylation 
sequons. 
Introduction 
Protein N-glycosylation is an important 
co-translational modification process wherein short 
sugar chains are covalently attached to the amide 
group of asparagine (N) residue in the amino acid 
chain [1]. N-glycosylation affects a number of proper-
ties of proteins such as solubility, stability and turn-
over, secretion, protease resistance, protein-protein 
interaction/recognition and immunogenicity, and 
hence has an immense biological importance [1-3]. 
Although asparagine occurs frequently in the protein 
chain, N-glycosylation requires asparagine to be 
present in special motifs – NXS/T sequons (where X is 
any amino acid except proline which is avoided due 
to conformational hindrance and the third residue is 
either serine or threonine). Further, N-glycosylation 
occurs only on some sequons found in mem-
brane-bound or secretory proteins which are exposed 
to the enzyme oligosaccharyltransferase in the lumen 
of endoplasmic reticulum [1-6]. 
The human immunodeficiency virus-1 (HIV-1) 
envelope glycoprotein 120 (gp120) occurs as a trimeric 
complex, with each monomer in non-covalent associ-
ation with gp41 (a transmembrane viral envelope 
glycoprotein anchor) and interacts with its primary 
receptor – CD4 glycoprotein of the host T-lymphocyte 
[7-9]. The gp120 contains an average of 26 NXS/T 
sequons, and therefore can be extensively 
N-glycosylated. As much as 55% of the molecular 
mass of the gp120 is contributed by carbohydrates as a 
result of N-glycosylation of most of its potential 
N-glycosylation sequons and therefore it is one of the 
most heavily glycosylated molecules in nature [10-12]. Int. J. Biol. Sci. 2010, 6 
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The HIV-1 pathogenesis, to a large extent, has been 
attributed to the structural plasticity of the gp120, and 
in particular, to the variability of N-glycosylation [7, 9, 
13]. For example, inhibition studies have demon-
strated that proper N-glycosylation of gp120 is critical 
for the infectivity of the virus [14]. Mutation studies 
have indicated that N-glycosylation around the CD4 
binding site of the gp120 is required for high affinity 
receptor interaction [10, 15]. It has been suggested that 
the HIV uses this ‘glycan shield’ on gp120 for the 
purpose of host immune evasion [16]. 
Therefore, it may be hypothesized that under 
selection pressures, the gp120 must undergo rapid 
changes with respect to its N-glycosylation sequons 
[17]. For instance, under selection pressure by man-
nose-specific lectins, resistant HIV-1 strains showed 
marked depletion (up to eight out of 22) of the 
N-glycosylation sequons in gp120 regions distant 
from interacting sites [18]. Fluctuations in the variable 
regions of the gp120 itself has been shown to change 
the N-glycosylation sequons in the early stages of 
viral infection [19]. Likewise, it is reasonable to expect 
a long-term trend in the number of N-glycosylation 
sequons in gp120 under the selection pressure from 
the host immune system or anti-retroviral drugs since 
the passage of HIV to human hosts [16, 20]. 
To data, there are only a few studies which at-
tempted long-term tracking of N-glycosylation se-
quons. For example, while hemagglutinin of human 
influenza virus A/H3N2 was found to accumulate the 
sequons over time, the gp120 of HIV-1 showed only 
variations in the number and location of sequons, but 
not any particular trend over time [21]. Similarly, a 
recent study attributed the abundance of 
N-glycosylation sequons in the gp120 to Darwinian 
selection, but found no significant change in the 
overall number of sequons since the HIV-1 moved 
from primates to humans [22]. With this information 
in mind, we sought to answer a different set of ques-
tions. Is there any location specific variability in the num-
ber and/or distribution of N-glycosylation sequons in the 
gp120? And what direction its evolution has been taking 
since the viral passage to human hosts? Finding answers 
to these questions may be important and relevant as 
they may have implications in understanding the 
gp120 evolution, and viral infectivity and resistance 
[23]. 
Materials and Methods 
Sequence acquisition 
The HIV-1 envelope gp120 sequences were 
downloaded from the HIV database at Los Alamos 
National Laboratory (http://www.hiv.lanl.gov/ 
content/index). Only the sequences with information 
about the year of sampling were used in this study. 
Further, sequences containing ambiguous amino ac-
ids were discarded. The final set constituted 11333 
amino acid (and corresponding nucleotide) sequences 
from 29 years (from 1981 to 2009). As our main aim 
was to find the general patterns of sequon variability 
in the gp120 of HIV-1 [17, 22], we have analyzed the 
sequences by taking all subtypes together. However, 
we have also analyzed the sequences from subtypes 
separately (62% sequences were from subtype B, 24% 
from subtype C and 14% from rest of the minor sub-
types) [21] and results have been presented wherever 
appropriate. 
Prevalence of NXS/T sequons 
The number of NXS/T sequons (NXS and NXT, 
where X is any amino acid except proline) and NPS/T 
sequences were counted in each amino acid sequence. 
Overlapping sequons, if any, have been taken as sep-
arate sequons. The first half of the sequence was con-
sidered as the N-terminal region and the second half 
as the C-terminal region. When a sequence contained 
odd number of amino acids, additional amino acid 
was added to the C-terminal region. The NXS/T se-
quons were also enumerated in N and C-terminal 
regions separately. The sequon density was consi-
dered as the number of sequons per 100 amino acids. 
The percentage of N, P, S and T amino acids in the full 
sequence and in the two regions were computed form 
their respective frequencies over the total number of 
amino acids. Regions of gp120 having high probabil-
ity of sequon occurrence were located (Figure 2) 
merely by stacking the sequences together after nor-
malization for mean sequence length (510 amino ac-
ids). 
Prediction of NXS/T sequon numbers 
The probabilistic occurrence of NXS/T sequons 
was computed form the transition of amino acid fre-
quencies by considering protein sequence as a Mar-
kov chain [6]. Accordingly, an ideal protein with all 20 
amino acids in equal proportions has 0.00475 proba-
bility (per amino acid) of containing a NXS/T sequon. 
Thus, a protein sequence of 400 residues has 1.9 pre-
dicted NXS/T sequons. As an example, gp120 se-
quence (AY247224, year 1981) with 512 residues has 
25 NXS/T sequons. But, only six sequons (44/512 * 
489/512  * 75/512 * 512 = 6.15) may be predicted for 
this sequence based on amino acid transitions. 
Percentage of A and T nucleotides 
The AT content (asparagine is encoded by AT 
rich codons) has previously been identified as one of 
the possible evolutionary mechanisms to modulate Int. J. Biol. Sci. 2010, 6 
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the sequon numbers in glycoproteins [22]. Thus per-
centage of adenine and thymine were computed form 
their respective frequencies in the full, and in the N 
and C-terminal regions of the corresponding nucleo-
tide sequences. 
Computing the distribution probability of sequons 
The distribution of NXS/T sequons in amino 
acid chain was modeled based on balls-in-boxes clas-
sical occupancy [24-29]. In brief, given n balls ran-
domly distributed to equal number of boxes with 
equal probability, the number of possible distribu-
tions (empty boxes are allowed and the order of the 
distribution is ignored) follows the partition number 
[25]. Similarly, given n number of sequons, the amino 
acid chain may be subdivided into a maximum of n 
equal parts. Although the number of possible distri-
butions is equal to the partition number, the given 
integer number of sequons can attain only one par-
ticular distribution at a time and the probability of 
that particular distribution is given by the formula: 
Pr(r1, r2, . . . , rn) = 1/nr * r!/(r1! * r2! * . . . * rn!) * r!/(q0! * 
q1! * . . . * qn!) 
Where, r is the number of sequons in a protein 
sequence, n is the number of partitions (is equal to r) 
on the protein sequence, ri is the number of sequons in 
any given partition, qi is the number of partitions with 
the same number of sequons and ! is the factorial 
function [25, 29]. As an example, all the possible dis-
tributions and respective distribution probabilities for 
r = 6 is presented in Table S1. In order to avoid too 
many decimals, log10 distribution probability was 
used. 
Data analysis 
The sequence analyses and data handling were 
done using programs written in the Python pro-
gramming language (ver. 2.6, 
http://www.python.org/). The Biopython 
(http://biopython.org/) tools were used for se-
quence-parsing. A Microsoft Excel 2003/2007 
spreadsheet was used to visualize the data and Sig-
maPlot (ver. 11, Systat Software Inc, CA, USA) was 
used to make the contour maps. A linear regression 
line was fitted to the scatter plots of mean (±  95% 
confidence interval) values versus year and Pearson’s 
correlation coefficient (r) was computed between the 
two variables. Owing to the large sample size, para-
metric tests were favored and means were declared 
significant at p < 0.05. A Student’s t test was used to 
see if the difference between the actual and the pre-
dicted mean values were significant. A significance 
test was also performed for the slope using the ob-
served statistic over the estimated standard error of 
the statistic and the t-value was given wherever ap-
propriate. A Z-test for two proportions or two sample 
means was used wherever applicable. 
Results 
N-glycosylation sequons in HIV-1 gp120 
The HIV-1 gp120 has an average of 25.6 (±2.4, 
standard deviation) N-glycosylation sequons and a 
mean sequence length of 509.49 (±9.26) amino acids. 
Although the number and position of sequons are 
variable in different gp120 sequences (Figure 1), dis-
tinct clusters of sequons may be observed. Figure 2 
shows the relative probability of finding sequons in 
the gp120 (n = 11333 sequences). The discrete peaks 
indicate rather steady occurrence of sequons in par-
ticular regions. Further, the NXS and NXT sequon 
regions are clearly distinguishable. It may be noticed 
that on or near the protein interaction regions 
(marked by green arrow-heads), for example, at 
amino acid position 425–430 (CD4 binding site) [7, 15], 
the sequon probability is virtually zero. Further, parts 
of the variable loops (V1/V2 and V3) do not contain 
any N-glycosylation sites (Figure 2). 
 
Sequon density in gp120 
The gp120 has an average sequon density 
(number of sequons per 100 amino acids) of 5.02 
(±0.43) with higher density (5.71±0.58) in the C ter-
minal region compared to the N terminal (4.29±0.59). 
Further, the C terminal region has much higher NXT 
sequon density. In contrast, the predicted sequon 
density in gp120 is nearly 3.84 times lower (Figure S1 
A and B). The predicted NXS density is significantly 
higher (p < 0.05, t = 3.54) in the C terminal region, as is 
the percentage of serine (5.47% versus 6.06%). There is 
no significant change in the NXS/T sequon density in 
the gp120 molecule over time (between 1981 and 
2009). However, NXS sequons, when considered 
alone, show a significant increase (p < 0.05, t = 3.24) 
(Figure S2 A and B). The sequon density (NXT) is in-
creasing in the N terminal region. In the C terminal 
region, NXS density is increasing and the NXT den-
sity is decreasing (Figure 3 A and B). These changes 
are much stronger when considered from the year 
1988 onwards (arrows in Figure 3 B). Similar trends 
were observed for sequons in gp120 of HIV-1 subtype 
B (Figure 3 C and D). Although a comparable pattern 
was seen in subtype C (sequences available only from 
1988 onward) the changes were not significant (data 
not shown). Inclusion of multiple gp120 sequences, if 
any, from same patients did not alter the overall pat-
tern of sequon density and distribution. Int. J. Biol. Sci. 2010, 6 
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Figure 1. N-glycosylation sequons in gp120. The N-glycosylation sequons vary in number and distribution in gp120 as 
exemplified here by three sequences AY247224 from 1981 (top), EU289201 from 1995 (middle) and GU080199 from 2009 
(bottom). The NXS sequons are represented as small black rectangles and NXT as white rectangles. The C terminal regions 
of the sequences are gray shaded. 
 
Figure 2. Occupancy of N-glycosylation sequons. The relative probability of the occurrence of sequons along the gp120 
sequence has very distinct peaks. Sequon probability is almost zero on or near the binding site regions. The NXS probability 
is shown in red and NXT in blue. Binding site regions are pointed by using green arrow-heads. Variable regions of the gp120 
sequence are indicated on the top (n = 11333 sequences). 
 
Figure 3. Sequon density in gp120. The N and C terminal regions of gp120 have very different sequon densities. (A) The 
increase in NXT density over time in the N terminal region is significant (t = 2.88, p < 0.05). (B) The C terminal region has 
very high NXT density which is significantly decreasing (t = -4.08) over time, but NXS is increasing (t = 3.81). Comparable 
patterns are observed (C and D) when gp120 of HIV-1 subtype B is considered alone. 
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AT content and sequon specific amino acids in gp120 
The AT content in the N and C terminal regions 
of the gp120 are significantly different (p < 0.05, 
56.46% versus 62.26%). Further, the AT content is de-
creasing in the whole gp120 molecule over time. This 
decrease is significant (p < 0.05, t = -2.32) also in the N 
terminal region, but not in the C terminal region 
(Figure 4A). 
The overall percentage of T and P amino acids 
are higher in the N terminal part of the gp120, while N 
and S are higher in the C terminal part. The percen-
tage of sequon specific amino acids N, S and T have 
not changed much over time in the whole gp120 mo-
lecule (Figure S3 B). However, when considered sep-
arately in the two regions, N and T amino acids show 
interesting trend. The percentage of N amino acid is 
increasing and T is decreasing in the N terminal re-
gion (Figure 4B). This trend is quite reversed in the C 
terminal region (Figure 4C). The proline is signifi-
cantly increasing in the whole gp120 and in the C 
terminal region (Figure 4B and 4C). 
Distribution of sequons in gp120 
The distribution of sequons in gp120 was mod-
eled based on classical occupancy [25, 29]. The calcu-
lation of log10 distribution probability is exemplified 
in table S1. It may be observed from Figure 5 that the 
distribution probabilities of sequons in the gp120 or in 
its two regions form very distinct clusters and are 
much closer to the maximum distribution probability 
line, indicating the probabilistically simpler 
near-random distribution of sequons. The overall 
distribution of NXS/T sequons in the gp120 has re-
mained same over time. However, NXT distribution, 
when considered alone has been increasing signifi-
cantly (p < 0.05, t = 4.28). The distribution of sequons 
is changing in the N terminal part of the gp120 as 
evidenced by the decreasing distribution probability 
(Figure S4 A and B). This is not significant when NXS 
and NXT sequons are considered separately. But in 
the C terminal region, the NXT sequon distribution 
probability is increasing, indicating a change towards 
the probabilistically simpler distribution over time 
(Figure 6 A and B). Similar trends were observed for 
the distribution of sequons in gp120 of HIV-1 subtype 
B (Figure 6 C and D). 
Figure 7 shows the relative probability of finding 
sequons in the gp120 over time. It is clear that the 
probability of finding sequons is not random over 
gp120 or over time, but very is distinct. The two re-
gions of the gp120 have different probabilities of NXS 
and NXT sequons. It may be noted that there are clear 
indications of emergence of new sequons (marked by 
black ovals) both NXS (for instance near amino acid 
positions 400 and 450) and NXT in the recent years 
(Figure 7 A and B). The directed disappearance of 
sequons is not so obvious due to overall high proba-
bility of sequons in much of the gp120 molecule. 
 
 
Figure 4. Percentage of AT and sequon specific amino acids in gp120. (A) The AT content is significantly lower in the C 
terminal region and decreasing (t = -2.32) over time. (B) The percentage of N and T amino acids are changing significantly (t 
= 3.56 for N and t = -3.17 for T) in the N terminal region of gp120. (C) The direction of this trend is reversed (t = -2.13 for 
N and t = 6.33 for T) in the C terminal region. 
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Figure 5. Distribution probability of sequons in gp120. The log10 distribution probabilities of sequons form distinct clusters 
and are close to optimal maximum distribution probabilities. The even distribution probability is indicated by red line and the 
maximum distribution probability by green line. 
 
 
 
 
Figure 6. Distribution of sequons in gp120. (A) The log10 distribution probabilities of NXS and NXT have remained same 
over time in the N terminal region. (B) The log10 distribution probability of NXT is increasing (t = 2.70) over time in the C 
terminal region. Comparable patterns are observed (C and D) when gp120 of HIV-1 subtype B is considered alone. 
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Figure 7. N-glycosylation sequons in gp120. (A) The contour map shows higher density of NXS in the N terminal region 
and emergence of NXS in the new locations (marked by black ovals). (B) The density of NXT is higher in the C terminal 
region. The apparent emergence of NXT in the new location is marked by a black oval. 
 
 
NPS/T sequences in gp120 
It may be noted that there is a total of 298 NPS/T 
three amino acid sequences in the entire set of gp120 
sequences (n = 11333) studied here. This observation 
is in stark contrast to the expected number of NPS/T 
sequences in the gp120 molecule. Based on Markov 
chain model, the predicted number of NPS/T se-
quences in 11333 gp120 sequences is 3544 (NPT is 
significantly higher) which is over 11.89 times higher 
compared to the observed number of NPS/T se-
quences (Figure S1 C and D). 
Discussion 
It has long been appreciated that the 
N-glycosylation sequons in gp120 are a changing 
phenotype which provides a mechanism for immune 
evasion [17, 21, 30]. However, little is known about 
the exact nature of this change – whether it is a mere 
fluctuation or a directional trend. In the present study, 
we attempted to track the number and distribution of 
sequons in two (N and C terminal) parts of the gp120 
molecule over time. The rational for dividing the 
gp120 sequence into two parts is two fold: First, the 
gp120 has two parts namely the inner and outer do-
mains [7]. The bulk of the N terminal part of the se-
quence forms the inner domain and the C terminal 
part forms the outer domain. The amino acid chain 
makes a transition from inner to outer domain be-
tween sheets β8 and β9, which is almost the mid point 
of the sequence. Second, it is known that the two do-
mains are unequally glycosylated with a higher pro-
portion occurring in the outer domain [31, 32]. This 
inequality may either be due to the preferential gly-
cosylation of sequons in the outer domain or simply 
that it contains many more sequons. It is clear from 
the present study that sequons are unequally distri-
buted in gp120, with outer domain containing much 
higher NXT sequon density (Figures 1, 2 and 3). It 
may be noted that the outer domain is much more 
exposed to solvent and has a number of regions, 
which interact with host proteins as compared to the 
i n n e r  d o m a i n  –  m u c h  o f  i t  i s  f a c i n g  g p 4 1  o r  i n n e r  
domains of gp120 monomers within the trimeric 
complex [7]. Therefore, higher sequon density in outer 
domain might have evolved as a protective mechan-
ism against neutralizing antibodies [16, 32, 33]. 
In agreement with previous findings [21, 22], the 
present study found no significant change over time 
in the number of NXS/T sequons in the whole gp120 
molecule. It has been postulated that there may be an 
upper bound to the number of sequons that can be 
maintained in the gp120 [21]. The gain or loss of se-
quons may influence the gp120/virus. For example, 
the glycan structures are quite bulky (~2000 Da) and 
therefore, the additional sequons may not provide a 
selective advantage due to conformational instability 
or functional redundancy. Similarly, the loss of se-
quons may have fitness costs, as they lead to failure of 
infectivity/immune evasion [34]. However, the 
present study shows a very clear directional change in 
the density (or number) of sequons in the two do-
mains of gp120. The NXT sequon density is decreas-
ing in the outer domain and the NXS sequon density Int. J. Biol. Sci. 2010, 6 
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is increasing. This is in contrary to the norm that the 
NXT sequons show a much higher Darwinian selec-
tion and are often preferentially glycosylated com-
pared to NXS sequons [4-6, 22]. In the current scena-
rio, NXS sequons must be rendering a selective ad-
vantage to the outer domain of gp120 molecule. Ap-
parently, the sequons were initially (from 1981 to 
1988) changing in directions opposite to the current 
ones (arrows in Figure 3). This trend is specific for 
gp120 of HIV-1 subtype B (Figure 3 C and D). The 
reason for this turnaround is not known, but the 
overall changes in the sequon density may be the re-
sult of antigenic drift since the viral passage to human 
hosts [8, 16, 18-21]. Directional changes in the sequons 
were not very obvious in subtype C and other minor 
subtypes due to narrow sampling period. Results 
presented here, therefore, may be characteristic of the 
major subtype B. 
The increase in NXS density is significant even 
when gp120 molecule is considered as a whole. It is 
interesting to note that there is no net change in the 
NXT sequon density in the whole gp120 molecule. 
This is because the decrease in NXT density in outer 
domain is compensated by significant increase in NXT 
density in inner domain over the time period between 
1981 and 2009. It may be recalled that previous studies 
failed to notice these intricate trends, instead reported 
mere fluctuations in the sequon numbers in gp120 
over time [21, 22]. This is not surprising because they 
either considered both the sequons together in the 
whole gp120 molecule [22] or were too early to detect 
such a trend in a subset (up to year 2000) of currently 
available gp120 sequences [21]. 
The increase in the content of AT (asparagine is 
encoded by AT rich codons) and sequon specific 
amino acids were previously been identified as the 
possible evolutionary mechanisms to modulate the 
sequon numbers in glycoproteins [22]. However, none 
of these mechanisms are at work here. The AT content 
is decreasing in the whole gp120 molecule and in the 
inner domain, but not in the outer domain. Further, 
the NXT density in outer domain is decreasing despite 
significant increase in the T amino acid. This trend is 
quite reversed in the inner domain (Figure 4). Another 
interesting mechanism to modulate sequon numbers 
is through NPS/T [6]. As the proline containing se-
quences (NPS/T) are not used for glycosylation due 
to conformational hindrance, sequon numbers can be 
increased or decreased simply by replacing/removing 
proline in NXS/T during evolutionary time course. In 
gp120, this mechanism contributed much to the se-
quon increase (not during the recent years). It may be 
noted that as against just 3.8 fold increase in the 
NXS/T density, there is an 11.9 fold decrease in the 
number of NPS/T sequences (Figure S1). On the other 
hand, the actual number of NPS/T sequences was 
shown to be significantly higher than expected in 
glycoproteins (such as ABC proteins) which contain 
very low sequon density [6]. 
The changes in the number or type of sequons 
also change the distribution of sequons. However, 
distribution of sequons can also be changed without 
changing the number or type of sequons. Due to the 
unequal number of NXS and NXT sequons in the two 
domains of gp120, their distributions are obviously 
‘uneven’ in the whole gp120 molecule. It may be 
noted that there are no studies modeling the distribu-
tion of sequons in gp120. The present results show 
that the distribution probabilities of NXS and/or NXT 
sequons in gp120 or in its two domains are very close 
to the maximum distribution probability (Figure 5). 
That is, the sequons attain a distribution which has a 
maximum or near-maximum probability of occur-
rence based on the random mechanism [25, 29]. This is 
very different from the ‘even’ distribution (which is 
simply one out of many possible random distribu-
tions) one would expect for a given number of se-
quons. Poon et al. [17] suggested an ‘even’ distribu-
tion of sequons (in the functional space) on the as-
sumption that glycan groups are bulky and therefore 
sequons must have been selected to be evenly distri-
buted to avoid conformational hindrance or function-
al redundancy. By contrast, a non-random distribu-
tion of sequons in gp120 was shown to be essential for 
infectivity of HIV-1 [35]. Here, uniform distribution 
was inaptly considered as random and hence the term 
‘non-random’ means a distribution which is not even. 
As seen by the increasing distribution probabil-
ity, the re-distribution of NXT sequons in gp120 over 
time (from 1981 to 2009) can be taking place according 
to the random process [29]. Similarly, as a result of 
decreasing density, the distribution of NXT is chang-
ing towards a more random one in the outer domain 
(Figure 6). On the other hand, large change (decreas-
ing probability) in the distribution of NXS/T sequons 
in inner domain is against random process. That is, 
there must be a selective advantage for this change 
and gp120/virus must have an evolutionary me-
chanism to attain this directed change. Interestingly, 
as a result of changing number and distribution, 
gp120 appears to be accumulating sequons in new 
locations (Figure 7). For example, the emergence of 
NXS sequons in the outer domain – near amino acid 
positions 400 and 450, which fall in the variable loop 
regions V4 and V5, respectively. The position of se-
quons is important in protein interactions – both an-
tibody avoidance and receptor binding [36-40] and 
sequons in relatively constant positions tend to be Int. J. Biol. Sci. 2010, 6 
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high-mannose type glycans, while sequons in shifting 
positions tend to have complex type glycans. It is 
shown that macrophage-derived viruses tend to be 
more neutralization resistant as their gp120 contains 
complex glycans on the shifting sequons [41]. The 
gain or loss of sequons and their distribution in gp120 
may give a selective advantage for the virus to evolve 
against host immune response. For example, it is 
shown that cumulative depletion of sequons in simi-
lar locations affect the infectivity of SIV [34]. The se-
quons may also vary depending on early/late stages 
of viral infection and sequence length variability itself 
has shown to affect the pattern of sequons (by selec-
tive addition or elimination) in gp120/viruses within 
infected individuals [19, 36]. The results presented 
here show delicate changes in the distribution of se-
quons in gp120 (chiefly for major subtype B) taking 
place over a long period since the viral passage to 
human hosts. However, our results must be viewed in 
the context of many factors (as mentioned previously) 
which affect sequons in gp120. 
In summary, we have shown that there are di-
rectional trends in both the number and distribution 
of N-glycosylation sites in HIV-1 gp120, with a clear 
selection for NXS sequons and rearrangement of NXT 
sequons. These observations indicate that the vi-
rus/subtypes must be currently (from 1981 to 2009) 
experiencing fitness benefits through the changes in 
the number and type of sequons, as well as their dis-
tribution, in the two domains of gp120.  
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Figures and Tables 
 
 
 
 
Figure S1. NXS/T sequons in gp120. (A) The observed density of NXS/T (where X is not proline) sequons in gp120. (B) 
The predicted density of NXS/T sequons is about four times lower compared to the observed density. (C) The observed 
number of NPS/T sequences in gp120. (D) The predicted number of NPS/T sequences is about 12 times higher compared to 
the observed number. 
0
1
2
3
4
5
NXS NXT
S
e
q
u
o
n
 
d
e
n
s
i
t
y
N terminal
C terminal
NXS NXT
N terminal
C terminal
A B
0
200
400
600
800
1000
1200
NPS NPT
T
o
t
a
l
 
n
u
m
b
e
r
N terminal
C terminal
NPS NPT
N terminal
C terminal
C DInt. J. Biol. Sci. 2010, 6 
 
http://www.biolsci.org 
417
 
Figure S2. Sequon density in gp120. (A) The NXS density is increasing (t = 3.24) over time in the whole gp120 molecule. 
(B) The NXS/T sequon density is increasing (t = 4.53) in the N terminal region. 
 
 
 
 
Figure S3. Sequence length and sequon specific amino acids in gp120. (A) There has been no significant change in the length 
of the sequence over time. (B) The percentage of sequon specific amino acids too remained same over time in gp120. 
However, proline has been increasing (t = 5.08) over time. 
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Figure S4. Distribution of sequons in gp120. (A) The log10 distribution probability of NXT is increasing (t = 4.28) over time 
in the whole gp120 molecule. (B) The log10 distribution probability of sequons in the N terminal region is decreasing (t = 
-2.57) over time. 
 
 
 
Table S1. Distributions and distribution probabilities. 
Sl. 
No. 
Partition  Count  Distribution 
probability 
Log10 distribution 
probability  1  2  3  4  5  6 
1  S S S S  S  S  1,1,1,1,1,1  0.015432
1 -1.812 
2   S S S  S  SS  0,1,1,1,1,2  0.231481 -0.635 
3     S  S SS  SS  0,0,1,1,2,2  0.347222
2 -0.459 
4       SS SS  SS  0,0,0,2,2,2  0.038580 -1.414 
5     S  S  S  SSS  0,0,1,1,1,3  0.154321 -0.812 
6       S SS  SSS  0,0,0,1,2,3  0.154321 -0.812 
7       SSS  SSS  0,0,0,0,3,3  0.006430 -2.192 
8       S S  SSSS  0,0,0,1,1,4 0.038580
3 -1.414 
9      SS  SSSS  0,0,0,0,2,4  0.009645 -2.016 
10       S  SSSSS  0,0,0,0,1,5  0.003858 -2.414 
11         SSSSSS  0,0,0,0,0,6  0.000129 -3.891 
 
 
1Even distribution – the distribution in which all the partitions are occupied. 
2Maxumum distribution – the distribution which has the maximum probability of occurrence. Here, 
Pr(0,0,1,1,2,2) = 1/66 * 6!/(0! * 0! * 1! * 1! * 2! * 2!) * 6!/(2! * 2! * 2! * 0! * 0! * 0! * 0!). 
3As an example, the distribution of NXT sequons in the N-terminal part of the gp120 (EU289201, year 1995) shown in Figure 1 is (0, 0, 1, 4, 0, 
1). 
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